Retraction notices

LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway

Type
Retraction
Notice date
12/30/2019 0:00
Journal
Cancer Cell International
Publisher
Springer - Biomed Central (BMC)
Notice DOI
10.1186/s12935-019-1084-7
Original paper DOI
10.1186/s12935-019-0778-1

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.